Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Bullboard Posts
Comment by Jo1987on Mar 14, 2020 11:24am
80 Views
Post# 30807511

RE:RE:RE:Minor Cannabinoids - Huge Potential

RE:RE:RE:Minor Cannabinoids - Huge Potential

Just so hard to gauge share price movements with these guys, especially in difficult times and on a heavily manipulated market.

What looks cheap today can just be cut in half within a week...

My fear in this entire sector of microcaps (and especially cannabis-related) companies is just that they let this little guys bleed out to take over the good parts for cheap. (Just recently happened with another one of my investsments. It won't cover my losses.)

I sold out of my Inmed position monday morning, limiting the pain at least on this one. (I have amassed enough losses in 2019/20.) Looking for a re-entry. But with (to my knowledge) no immediate catalysts, I am just wondering if i would regret getting in too soon again.

Bullboard Posts